I like GILD for fundamental reasons but the market is worried about declining hep c revenues and the chart is clear. could bottom here at 69-70, but if it goes below 69 I think we revisit 63 where there is pretty strong support. RSI is in a clear downtrend, which needs to be cleared before price and momentum can reverse positively